Heart failure: an update from the last years and a look at the near future

In the last years, major progress occurred in heart failure (HF) management. Quadruple therapy is now mandatory for all the patients with HF with reduced ejection fraction. Whilst verciguat is becoming available across several countries, omecamtiv mecarbil is waiting to be released for clinical use....

Descripción completa

Detalles Bibliográficos
Autores principales: Riccardi, Mauro, Sammartino, Antonio Maria, Piepoli, Massimo, Adamo, Marianna, Pagnesi, Matteo, Rosano, Giuseppe, Metra, Marco, von Haehling, Stephan, Tomasoni, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773737/
https://www.ncbi.nlm.nih.gov/pubmed/36546712
http://dx.doi.org/10.1002/ehf2.14257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773737/
https://www.ncbi.nlm.nih.gov/pubmed/36546712
http://dx.doi.org/10.1002/ehf2.14257

Ejemplares similares